GT Biotech Fund, LP — Form D

GT Biotech Fund, LP of Memphis, TN, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2020-03-16. Industry: Pooled Investment Fund.

Offering

Issuer

Officers, directors & promoters (19)

NameRoleLocation
Michael J DouglassExecutive OfficerMemphis, TN
Justin L RikardExecutive OfficerMemphis, TN
Darren T KearnsExecutive OfficerMemphis, TN
n/a Gerber/Taylor Management LLCExecutive OfficerMemphis, TN
n/a Gerber/Taylor Management LLCPromoterMemphis, TN
Simone T MeeksExecutive OfficerMemphis, TN
Ryan E GibbsExecutive OfficerMemphis, TN
Mary C CornpropstExecutive OfficerMemphis, TN
Charles C GerberExecutive OfficerMemphis, TN
David G EastExecutive OfficerMemphis, TN
William E PickensExecutive OfficerMemphis, TN
Justin T RikardExecutive OfficerMemphis, TN
n/a Gerber/Taylor Management CompanyPromoterMemphis, TN
Justin L. RikardRelated PersonMemphis, TN
Simone T. MeeksRelated PersonMemphis, TN
Ryan E. GibbsRelated PersonMemphis, TN
Mary C. CornpropstRelated PersonMemphis, TN
Michael J. DouglassRelated PersonMemphis, TN
Darren KearnsRelated PersonMemphis, TN

Other filings by this issuer (8)

FiledFormOfferingSold
2026-07-29D/A$233.5M
2025-07-29D/A$229.3M
2024-07-29D/A$221.6M
2023-07-28D/A$217.0M
2022-07-29D/A$194.6M
2021-07-30D/A$104.4M
2021-03-16D/A$61.2M
2020-04-13D/A$16.0M

More